NervGen Brings Advanced Imaging to Upcoming Trials & Socializing with MS

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses an article about how NervGen will use Imeka's biomarker imaging technology to measure changes in brain and spinal cord in its Phase 1b/2 trials.

Plus, Price reads the column by John Connor, Fall Down, Get Up Again, “Party on, Dude, but I’m Still Blaming the Dog!”

===================================

Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/